Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...

The FDA has approved the at-home use of AstraZeneca's FluMist nasal spray vaccine. A prescription will still be required. The vaccines will be available from an on-line pharmacy next fall.

World leaders are set to meet Tuesday for the U.N. General Assembly.

Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...

The EMA CHMP has recommended granting approval for AstraZeneca’s Fasenra for eosinophilic granulomatosis with polyangiitis ...

FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.

Bengaluru: AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Durvalumab 120 ...

The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).

There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...

FluMist won't be available until next year, according to the website for FluMist, which is owned by AstraZeneca. Once it does ...

The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...